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The increasing popularity of the Cre/loxP recombina-
tion system has led to the generation of numerous
transgenic mouse lines in which Cre recombinase is
expressed under the control of organ- or cell-specific
promoters. Alterations in retinal pigment epithelium
(RPE), a multifunctional cell monolayer that separates
the retinal photoreceptors from the choroid, are prev-
alent in the pathogenesis of a number of ocular disor-
ders, including age-related macular degeneration. To
date, six transgenic mouse lines have been developed
that target Cre to the RPE under the control of various
gene promoters. However, multiple lines of evidence
indicate that high levels of Cre expression can be toxic
to mammalian cells. In this study, we report that in the
Trp1-Cre mouse, a commonly used transgenic Cre
strain for RPE gene function studies, Cre recombinase
expression alone leads to RPE dysfunction and concom-
itant disorganization of RPE layer morphology, large
areas of RPE atrophy, retinal photoreceptor dysfunc-
tion, and microglial cell activation in the affected areas.
The phenotype described herein is similar to previously
published reports of conditional gene knockouts that
used the Trp1-Cre mouse, suggesting that Cre toxicity
alone could account for some of the reported pheno-
types and highlighting the importance of the inclusion
of Cre-expressing mice as controls in conditional gene
targeting studies. (Am J Pathol 2012, 180:1917–1927; DOI:
10.1016/j.ajpath.2012.01.017)
The retinal pigment epithelium (RPE) is a multifunctional,
cuboidal monolayer of cells that separates the retinal pho-toreceptors from the choroid. The RPE is an essential com-
ponent of the vertebrate retina and performs diverse func-
tions, including the formation of the outer blood retinal
barrier, the phagocytosis of photoreceptor outer disk seg-
ments, and the regeneration of 11-cis retinal for the visual
cycle.1,2 Dysfunction of the RPE has been linked with a
variety of ocular disorders, including age-related macular
degeneration and retinitis pigmentosa, among others.
The Cre-loxP recombination system has been instrumen-
tal in dissecting the spatial and temporal functions of many
important genes involved in development, physiology, or
disease through the generation of organ- or cell-specific
knockout animals. It is an elegant technique to bypass lethal
or severe developmental defects that result from systemic
ablation of essential genes.3 Cre recombinase is a 38-kDa
protein that catalyzes the recombination between two of its
loxP recognition sites, a 34-bp sequence consisting of a
core 8-bp sequence and two 13-bp palindromic flanking
sequences.4 However, several lines of evidence indicate
that Cre expression can be toxic in mammalian cells be-
cause it can cleave mammalian DNA in a nonspecific man-
ner at sequences that share limited homology with the
34-bp loxP sequence.5 Pseudo/cryptic-loxP sites that occur
naturally in Escherichia coli and in yeast and mammalian
genomes serve as low-affinity substrates for Cre recombi-
nase,6–8 and continuous exposure to high concentrations
of the enzyme triggers cleavage and recombination be-
tween these sites. These “illegitimate” recombinations can
result in growth inhibition, cell cycle arrest, DNA strand
breaks, or even gross chromosomal aberrations.9–11
Here, we report the phenotype induced by Cre expres-
sion in the RPE of the Trp1-Cre transgenic mouse strain,
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related protein 1 (Trp1/Tyrp1, hereafter referred as Trp1)
gene promoter. Trp1 belongs to the tyrosinase family of
proteins, which are uniquely expressed in melanin-syn-
thesizing cells, including the RPE. Trp1 is a glycoprotein
located in the melanosomal membrane that acts within
the context of a series of reactions in the melanogenic
pathway to control melanin production in melano-
somes.12 In this study we describe damage to RPE and
retina in the Trp1-Cre mouse that includes drastic
changes in gross cellular and ultrastructural morphology,
irregularities in gene expression, and electroretinogram
(ERG) abnormalities; these alterations are not exhibited in
their littermate controls.
Materials and Methods
Animals
All animal experiments followed the guidelines of the
Association for Research in Vision and Ophthalmology
Statement for the Use of Animals in Ophthalmic and Vi-
sion Research and were approved by the Animal Care
Committee of Massachusetts Eye and Ear Infirmary. The
transgenic mouse line expressing Cre recombinase un-
der the control of the Trp1 promoter was used for the
experiments.13 Genotyping of the Trp1-Cre transgenic al-
lele was performed with the following primer set: Trp1-CreF,
5=-GCGGTCTGGCAGTAAAAACTATC-3=, and Trp1-CreR,
5=-GTGAAACAGCATT GCTGTCACTT-3=, along with an in-
ternal control primer set, 5=-CTAGGCCACAG AATTGAAA-
GATCT-3= and 5=-GTAGGTGGAAATTCTAGCATCATCC-
3=, which produced amplicons of 102 and 324 bp,
respectively (see Supplemental Figure S1A at http://
ajp.amjpathol.org). The Trp1-Cre mouse strain was back-
crossed for at least 10 generations with C57Bl/6 mice. All
mice harboring the Trp1-Cre transgene were genotyped
for the retinal degeneration 1 mutation,14 and only mice
that did not carry the mutation were used for the experi-
ments. A minimum of six to eight animals were used for
each experiment. Genomic DNA from FVB/N mice was
obtained from The Jackson Laboratories (Bar Harbor,
ME) and used as a positive control for the retinal degen-
eration1mutation(seeSupplementalFigureS1Bathttp://ajp.
amjpathol.org). Littermate mice not carrying the Cre trans-
gene were used as controls for all experiments. The
ROSA26R reporter gene mouse was obtained from The
Jackson Laboratories.15 Anesthesia was achieved by intra-
peritoneal injection of 50 mg/kg ketamine hydrochloride
(Phoenix Pharmaceutical, Inc., St. Joseph, MO) and 10
Table 1. Antibodies Used in This Study
Antigen Host Immu
RPE 65 Rabbit 1:1
-catenin Mouse 1:2
Cre-recombinase Rabbit
FITC-ZO1 Goat
Iba-1 Rabbit
-tubulin Rabbit 1:2000mg/kg xylazine (Phoenix Pharmaceutical, Inc.), and pupils
were dilated with topical 0.5% tropicamide (Alcon, Huma-
cao, Puerto Rico).
Immunohistochemistry of RPE Flat Mounts
Under deep anesthesia mice were perfused through the
left ventricle with 10 mL of PBS followed by 10 mL of 4%
paraformaldehyde. Eyes were enucleated, and the ante-
rior segment and retina were removed under a dissecting
microscope. Special attention was paid during the re-
moval of the retina to avoid damage of the underlying
RPE. Four relaxing radial incisions were made, and the
remaining RPE-choroid-sclera complex was flat mounted
on a glass slide. Flat mounts were air-dried for 10 minutes
and incubated for 1 hour with blocking solution (5% don-
key serum, 0.3% bovine serum albumin, 0.3% Triton-X).
Primary antibodies were incubated overnight at 4°C in a
moisture chamber. A full list of antibodies as well as their
working concentrations is shown in Table 1.
X-Gal Staining for -Galactosidase Activity
For whole-mount X-Gal staining, eyes were enucleated and
fixed for 7 minutes in 4% paraformaldehyde. After fixation,
eyes were washed thoroughly three times with wash buffer
(0.1 mol/L sodium phosphate, 2 mmol/L MgCl2, 0.01% de-
oxycholate, 0.02% Nonidet P-40). Immediately after wash-
ing, eyes were placed in prewarmed (37°C) X-Gal staining
solution (5 mmol/L K3Fe(CN)6, 5 mmol/L K4Fe(CN)6-6H2O
diluted in wash buffer) and X-Gal (5-bromo-4-chloro-3-indo-
lyl -D-galactopyranoside; Sigma-Aldrich, St. Louis, MO)
was added to a final concentration of 1 mg/mL. Eyes were
protected from light and incubated at 37°C overnight. For
tissue sections, eyes were enucleated and embedded into
optimal temperature cutting medium (Tissue-Tek OCT;
Sakura, Alphen aan den Rijn, The Netherlands). Serial sec-
tions of 10 m were cut using a cryostat (Leica Microsys-
tems, Buffalo Grove, IL) and assayed for -galacatosidase
activity, as described above. To better visualize X-gal stain-
ing in the RPE, pigment was bleached (after X-gal staining)
by incubation in KMnO4 (0.25% in water) for 35 minutes at
room temperature (protected from light) and subsequent
incubation in oxalic acid (1% in water) for 20 minutes at
room temperature.
Fluorescein Angiography
Fluorescein angiography (FA) was performed with a com-
mercial camera and imaging system (TRC 50 VT camera
Immunostaining Supplier
– Abcam
1:100 Millipore
1:400 Millipore
1:100 Invitrogen
1:100 Wakonoblot
000
000
–
–
–– Cell Signaling
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tographs were captured with a 20-diopter lens in contact
with the fundus camera lens after intraperitoneal injection
of 0.1 mL of 2% fluorescein sodium (Akorn, Decatur, IL).
ERG Analysis
ERGs were recorded as previously described.16 Briefly,
after an overnight dark adaptation mice were anesthetized
with sodium pentobarbital at 80 mg/kg given intraperitone-
ally. Their pupils were dilated with 0.2% phenylephrine and
0.02% cyclopentolate hydrochloride. Full-field, rod-dom-
inant (95%) ERGs were elicited in the dark with 10-
second flashes of white light (1.37105 cd/m2) pre-
sented at 1-minute intervals in a Ganzfeld dome. Light-
adapted, cone responses were elicited in the presence of
a 41-cd/m2 rod-desensitizing white background with the
same flashes (1.37105 cd/m2 presented at 1 Hz). Cone
responses were collected with signal averaging.
Electron Microscopy
Eyes were enucleated under deep anesthesia, and the
globe was cleaned of all extraneous tissue then rinsed
with saline. The globe was immediately placed into fixa-
tive consisting of 2.5% glutaraldehyde and 2% formalde-hyde in 0.1 mol/L cacodylate buffer with 0.08 mol/L CaCl2
at 4°C. After a short 10- to 15-minute fixation, the eye was
bisected at the limbus, the anterior segment was sepa-
rated from the posterior segment, and the parts to be
examined were placed back in the fixative. Within 24
hours of enucleation, the tissue was washed in 0.1 mol/L
cacodylate buffer and stored at 4°C. The tissue was
postfixed for 1.5 hours in 2% aqueous OsO4. Tissue was
dehydrated in graded ethanols, transitioned in propylene
oxide, infiltrated with propylene oxide and epon mixtures
(TAAB 812 resin; Marivac, Quebec, QC, Canada), em-
bedded in epon, and cured for 48 hours at 60°C. One-
micron sections were cut on a Leica Ultracut UCT and
stained with 1% toluidine blue in 1% borate buffer. For
transmission electron microscopy observation, thin sec-
tions were cut at 70 to 90 nm and stained with saturated,
aqueous uranyl acetate and Sato’s lead stain. Examina-
tion was done on a Philips CM-10 electron microscope
(Philips Healthcare, Amsterdam, The Netherlands).
Animal Spectral Domain Optical Coherence
Tomography
Optical coherence tomography was performed with a
spectral domain optical coherence tomography system
Figure 1. -galactosidase activity in the Trp1-
Cre;ROSA26R line. Sagittal frozen sections show-
ing Cre expression in the ciliary margin of the
retina (A), with magnified images of the ciliary
body (B) and RPE (C); X-Gal staining is blue
(arrows). D: ROSA26R control RPE. Represen-
tative RPE flat mounts from Trp1-Cre;ROSA26R
(E and F) mice showing the extent of Cre ex-
pression in the RPE and peripheral retina, which
was folded over for better visualization of X-Gal
staining (blue; arrows). Melanin bleaching
(F–H) to identify the percentage of Cre-express-
ing cells. No -galactosidase activity was ob-
served in ROSA26R controls incubated with X-
Gal staining solution (D, G, and H). Scale bars:
100 m (A), 150 m (B), 50 m (C and D), 500
m (E–H).
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Briefly, a volume analysis centered on the optic nerve
head was performed, using 100 horizontal, raster, and
consecutive B-scan lines, each one composed by 1200
A-scans. The volume size was 1.6 1.6 mm. Total retinal
thickness and outer nuclear layer thickness was as-
sessed at distances of 500 m, 400 m, and 300 m
from the optic nerve head (nasally and temporally) and at
200 m above and 400 m below the optic nerve head.
Western Blot Analysis
The choroid-RPE tissue from Trp1-Cre mice and respective
controls was separated from the retina and homogenized in
lysis buffer,18 supplemented with a mixture of proteinase
inhibitors (Complete Mini; Roche Diagnostics, Basel, Swit-
zerland). The samples were centrifuged (14,000 rpm for 30
minutes at 4°C), and supernatant fluids were collected.
Protein concentration was assessed with the bicinchoninic
acid protein assay (Pierce, Rockford, IL). Thirty micrograms
of protein per sample were separated in a 4% to 20%
gradient SDS-PAGE (Invitrogen Corporation, Carlsbad,
CA), and the proteins were electroblotted onto polyvi-
nylidene difluoride membranes. After 20 minutes of incuba-
tion in blocking solution (Starting Block T20; Thermo Scien-
tific, Waltham, MA), membranes were incubated with
Figure 2. Morphologic abnormalities of RPE monolayer of the Trp1-Cre mou
disorganization of RPE cells (B and D) with loss of its classic honeycomb a
F arrows) was also observed compared with wild-type controls (C and E).
(I) in Trp1-Cre mice. J: Western blot analysis of choroid-RPE protein lysates
expression levels. K: Densitometric analysis of -catenin expression. Error bars indic
D–F). **P  0.01, ***P  0.001.primary antibodies overnight at 4°C. Table 1 includes a full
list of antibodies and their working concentrations. Peroxi-
dase-labeled secondary antibodies (Amersham Pharmacia
Biotech, Piscataway, NJ) were used, and proteins were
visualized with enhanced chemiluminescence technique
(Amersham Pharmacia Biotech).
ELISA
Analysis of IL-10 production was performed using a
quantitative ELISA kit (R&D Systems, Minneapolis,
MN). After perfusion with 10 mL of PBS, choroid-RPE
lysates from wild-type and Trp1-Cre mice were col-
lected and assayed for IL-10 protein levels according
to the manufacturer’s instructions. Values were normal-
ized to lysate protein levels.
Statistical Analysis
Values are expressed as mean SEM (unless specified),
and statistical analysis was performed with an unpaired
Student’s t-test or with the non-parametric Mann-Whitney
U test for unequal variances.
unohistochemical staining for the junctional protein -catenin showed severe
ce (A and C). Substantial loss of -catenin membranous association (D and
ant decrease in cell density (G), increase in cell size (H), and cell perimeter
ld-type and Trp1-Cre mice showed significant decrease in -catenin proteinse. Imm
ppearan
Signific
from wiate SD (G, H, and I) and SEM (K). Scale bars: 50 m (A and C), 200 m (B,
ttened R
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Expression Pattern of Cre-Recombinase in the
Trp1-Cre Mouse
To evaluate the expression pattern of Cre recombinase in
the Trp1-Cre transgenic mouse strain, adult 2-month-old
Trp1-Cre mice were crossed with the ROSA26 reporter
gene mouse to yield a Trp1-Cre;ROSA26R line. Upon Cre
gene expression, the recombinase activity results in the
excision of a loxP-flanked STOP sequence that prevents
expression of a lacZ gene.15 Thus, -galactosidase staining
reflects Cre recombinase activity in vivo. We confirmed that
the Trp1-Cre mouse provided robust Cre expression in the
RPE (Figure 1C). To estimate the percentage of Cre-ex-
pressing cells, X-Gal staining and subsequent melanin
bleaching were performed on whole eyecups of Trp1-Cre;
ROSA26R mice. A variable degree of mosaicism in Cre
expression was observed, ranging from 60% to 90% of total
Figure 3. Pigmentary defects in Trp1-Cre mice. A and B: Macroscopic e
wedge-shaped areas of depigmentation (arrows). C–H: Early- and late-pha
meridians. I–N: Perfusion with rhodamine-conjugated Concanavalin A lectin
RPE blocked the fluorescent signal from the choroid. In Trp1-Cre mice visual
of abnormalities in its pigmentation. O–Q: Large areas of depigmented and fla
compared with the uniform shape of wild-type RPE cells (Q). Scale bars: 500 m (ARPE cells (Figure 1F; see also Supplemental Figure S1C at
http://ajp.amjpathol.org). Ectopic Cre expression in other oc-
ular tissues was evident such as the ciliary margin of the
retina (Figure 1, A, B, and E), ciliary pigment epithelium
(Figure 1B), and optic nerve stalk (see Supplemental Figure
S1D at http://ajp.amjpathol.org). ROSA26R eyecups incu-
bated with X-Gal staining solution did not show any -ga-
lactosidase activity. (Figure 1, D, G, and H) Taken together,
these data indicate that the expression pattern of our Trp1-
Cre strain is consistent with the one described by Mori
et al13 in the initial description of the Trp1-Cre mouse.
Severely Altered RPE Morphology in the
Trp1-Cre Mouse
Intercellular tight junctions are critical for the mainte-
nance of RPE monolayer integrity. Adherens proteins,
such as -catenin, are important for intercellular adhe-
ion of RPE flat mounts from wild-type and Trp1-Cre mice showed large
owed large areas of hyperfluorescence at 10 o’clock (G) and 2 o’clock (H)
unterstaining with FITC-ZO-1. In wild-type mice, the melanin content of the
f the underlying large bore capillary bed of the choroid can be seen because
PE cells (enlarged in P; arrows) were seen on 1-m toluidine blue sections,xaminat
se FA sh
and co
ization oand B), 50 m (I–N), 100 m (P and Q).
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whereas tight junction proteins, such as zona occludens
(ZO)-1, have a fundamental role for the formation and
function of outer blood retinal barrier.19 To examine the
morphology of the RPE layer in the Trp1-Cre mouse,
immunofluorescent staining was performed on flat
mounts with the use of a monoclonal antibody against the
adherens junction protein -catenin. In Trp1-Cre mice,
the majority of the RPE monolayer had lost its classic
honeycomb appearance, and the cells were enlarged,
polygonal, and dysmorphic compared with wild-type
Figure 4. Ultrastructural analysis of the RPE of littermate controls (A–C) and
size (F and H) of RPE melanin granules were seen in Trp1-Cre mice compa
melanin granule (asterisk; F). The apical villi (AV) were collapsed and d
phagocytic granules in the subretinal space (E, outline). AV, apical villi, BLI, basal la
M, macrophage/microglial cell; POS, photoreceptor outer segment. n  6 eyes percontrols (Figure 2, A–F). Quantitative analysis showed a
dramatic decrease in RPE cell density (number of cells
per unit area; Figure 2G). Average cell size and perimeter
were found to be significantly higher in Trp1-Cre mice
compared with wild types (Figure 2, H and I). Similar
results were obtained after immunostaining with a fluo-
rescein isothiocyanate (FITC)-conjugated monoclonal
antibody against ZO-1 (see Supplemental Figure S2A at
http://ajp.amjpathol.org). Furthermore, although -catenin
is mostly associated with the cell membrane, an aberrant
cytoplasmic distribution was evident, indicating a distur-
1-Cre mouse (D–I). Abnormalities in the number (D and I), shape (E), and
the fusiform shape of wild-type controls (A–C). Notice the unusually large
tegrate with photoreceptors, as in wild-type RPE. Microglial cell (M) withthe Trp
red with
id not inminar infolding; BRM, Bruch’s membrane; CC, choriocapillaris; CH, choroid;
group. Scale bars: 1 m (A, B, D, and I), 2 m (C), 2.5 m (E, F, and G).
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ure 2, D and F). The latter was accompanied by a reduc-
tion of protein expression as shown by Western blot
analysis on 2-month-old choroid-RPE lysates (Figure 2, J
and K). Finally, immunofluorescent staining with a mouse
monoclonal antibody against Cre recombinase found nu-
clear localization of the protein as expected (Figure 2F).
Pigmentary Defects in the RPE of the Trp1-Cre
Mouse
Macroscopic examination of RPE flat mounts from Trp1-
Cre mice found wedge-shaped areas of pigmentary de-
fects that were extending from the mid-periphery until the
ora serrata compared with control (Figure 3, A and B). To
further examine this finding, FA was performed in adult
1-month-old animals. The pigmentary defects observed
previously corresponded to areas of hyperfluoresence
that increased in intensity over time but not in size (win-
dow defect) (Figure 3, C–H). These defects were bilateral
and interestingly found at all times in similar position in
the periphery of the eye (2 and 10 o’clock meridians). In
addition, late-phase angiograms of Trp1-Cre mice found
diffuse background hyperfluorescence (Figure 3, G and
H). Next, Trp1-Cre and wild-type littermate controls were
perfused with rhodamine-conjugated concanavalin-A
lectin and counterstained the overlying RPE layer with a
FITC-conjugated antibody against ZO-1 (Figure 3, I–N).
Figure 5. Retinal abnormalities in Trp1-Cre mice. A: Representative dark
Amplitudes of both a-waves and b-waves were reduced in Trp1-Cre mice. n
optical coherence tomography at the level of optic nerve (arrow) and 200 m
outer nuclear layer thickness (orange arrow). C and D: Significant decrease in total r
E: Western blot analysis of choroid-RPE lysates for RPE65 protein expression levelsAs expected, in wild-type animals the RPE layer pre-
cluded visualization of the underlying choroid because of
its dense melanin content (Figure 3, I–K), whereas in
Trp1-Cre mice the choroidal vasculature was visible be-
neath the RPE, indicating a defect in its pigmentation
(Figure 3, L–N), which may account, at least in part, for
the diffuse background hyperfluorescence observed on
FA. This was further supported from 1-m semithin sec-
tions stained with toluidine blue, where the RPE layer was
flattened with large discontinuities in its pigmentation
(Figure 3, O–Q).
Morphologic Abnormalities in the RPE of the
Trp1-Cre Mice
Next, the morphology of the RPE layer was assessed by
transmission electron microscopic analysis of adult
2-month-old wild-type and Trp1-Cre mice (Figure 4). A
substantial decrease was observed in the thickness of
RPE cells of Trp1-Cre mice with either loss or disorgani-
zation of the apical villi, which did not integrate with the
outer segments of photoreceptors (Figure 4, D–I). In ad-
dition, a reduction of basal laminar infoldings was noted
(Figure 4, E–H). Melanin granules were larger (Figure 4, E
and F) and irregularly shaped (Figure 4, E and H) com-
pared with the elliptical or spherical shape of wild-type
controls (Figure 4, A–C). RPE cells with little or no melanin
granules were also evident (Figure 4, D, G, and I). In line
and light adapted responses in 4-month-old control and Trp1-Cre mice.
 0.001 for both a and b waves. B: In vivo evaluation with spectral domain
(arrowhead) and measurement of total retinal thickness (blue arrow) andadapted
 4. P
aboveetinal thickness and outer nuclear layer thickness was seen in Trp1-Cre mice.
(n  6 eyes per group).
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AJP May 2012, Vol. 180, No. 5Figure 6. Microglial cell activation and migration to the subretinal space in the Trp1-Cre mouse. A–F: Iba-1-positive microglial cells were mostly confined to the
areas of injured RPE cells. G–I: Cellular debris stained positive for FITC-ZO1 co-localized with cell bodies of activated, amoeboid-shaped microglial cells (arrows).
J–L: Microglial cells were commonly associated with areas of dysfunctional RPE cell membranes, as indicated from the absence of ZO-1 immunostaining. Scale
bars: 200 m (A–C), 100 m (D–F), 25 m (G–L).
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were no abnormalities in the shape of choroidal mela-
nocytes (Figure 4, B, E–G), which do not express Cre
recombinase.13
Retinal Abnormalities in Trp1-Cre Mice
Given the critical role of the RPE in the maintenance and
function of the photoreceptor cell layer, retinal function of
Trp1-Cre mice was examined. Full-field dark-adapted
(rod) and light-adapted (cone) ERGs were recorded from
4-month-old animals (n 4 for each group). Both rod and
cone responses were significantly reduced in Trp1-Cre
mice compared with the ERG responses obtained from
wild-type mice counterparts (Figure 5A). Consistent with
the abnormal ERG data, a pronounced decrease in total
retinal thickness (Figure 5, B and C) and outer nuclear
layer thickness (Figure 5, B and D) was seen in Trp1-Cre
mice as examined in vivo with spectral domain optical
coherence tomography. Finally, Western blot analysis of
choroid-RPE lysates for RPE65, a protein abundantly ex-
pressed in the RPE that plays a critical role in retinoid
processing, showed a significant reduction in its expression
level compared with wild-type animals, suggesting possible
deficits in the visual cycle (Figure 5E).
Microglial Cell Activation in the Trp1-Cre Mouse
The retinal microglia constitute the resident macro-
phages of the retina and are among the first cells to
respond after tissue injury.20 Under normal conditions,
the retinal microglia are distributed throughout the retinal
layers with the notable exception of the subretinal space,
which is considered an immune-privileged site.21 To in-
vestigate whether Cre-mediated RPE damage triggers
microglial cell activation, immunofluorescent staining was
performed on RPE flat mounts with the use of an antibody
against the macrophage/microglial cell marker Iba-1, a
calcium-binding protein involved in membrane ruffling
and phagocytosis, which is significantly up-regulated
during microglial cell activation.22 No microglial cells
were detected in the subretinal space of wild-type
2-month-old mice (see Supplemental Figure S3, A–C, at
http://ajp.amjpathol.org). By contrast, immunofluorescent
Table 2. Studies That Have Used the Trp1-Cre Mouse to Inactiva
Targeted gene Ph
RXR Decreased expression of RPE65
in number; shortening of OS;
VEGF Microphthalmia; absence of cho
granules; abnormally shaped
infoldings; loss of apical villi;
(decrease in a and b wave); R
Lrat Reduced light responses on ER
reduction in photoreceptor nu
PTEN Retinal degeneration; reduction
CTNNB1 (-catenin) Microphthalmia; colobomas; dis
CTNNB1 (-catenin) Microphthalmia; colobomas; dis
RBP-J, Notch1, Notch2 Microphthalmia; benign pigmenCRALBP, cellular retinaldehyde-binding protein; ONL, outer nuclear layer; OSstaining of RPE flat mounts from Trp1-Cre mice showed a
dramatic accumulation of microglial cell in the subretinal
space, mostly at the areas of the damaged RPE (Figure 6,
A–F; see also Supplemental Figure S3, D–F, at http://ajp.
amjpathol.org). Furthermore, microglial cells acquired an
amoeboid-like morphology with short processes (Figure
6H) indicative of their phagocytic-activated state. More-
over, their cell bodies co-localized with cellular debris
stained positive for FITC-ZO-1 that was most likely origi-
nating from phagocytosed RPE cells (Figure 6, G–I; see
also Supplemental Figure S3, D–F, at http://ajp.amjpathol.
org). Finally, microglial cells were intimately associated
with areas of dysfunctional RPE cell membranes or areas
of RPE remodeling, as identified from the absence of
ZO-1 immunostaining of RPE cell membranes or the
structural changes of surrounding RPE cells, respectively
(Figure 6, J–L; see also Supplemental Figure S, 3K–M, at
http://ajp.amjpathol.org).
Discussion
The present study describes a phenotype in the Trp1-Cre
mice characterized by dramatic changes in the morphol-
ogy of the RPE monolayer, irregularities in its pigmenta-
tion, retinal dystrophy, and concomitant activation of the
retinal microglia in the affected areas. The described
phenotype had 100% penetrance with patchy distribution
and was observed in both male and female homozygous
mice for the Trp1-Cre transgene. In the Trp1-Cre strain,
Cre expression in the RPE starts from embryonic day 10.5
(time of RPE differentiation) to postnatal day 12,13 and
significant changes in RPE monolayer appearance were
evident also on postnatal day 14, indicating that Cre may
have exerted its toxic effect even before this time point (see
Supplemental Figure S2B at http://ajp.amjpathol.org).
It is known that the insertion of a Cre transgene or any
other transgene may affect the function of the upstream
gene promoter chosen to drive transgene expression. For
instance, CD19-Cre mice, which are used to evaluate
gene function in B cells, show 50% decrease in the levels
of CD19 expression compared with wild-type B cells.23
Similarly, rat insulin II promoter-Cre mice, expressing Cre
in pancreatic  cells, are glucose intolerant.24 Therefore,
the abnormalities in RPE pigmentation and melanosome
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AJP May 2012, Vol. 180, No. 5shape we observed in the Trp1-Cre mouse and previ-
ously reported by two other studies25,26 may be attrib-
uted to abnormalities in the function of Trp1 gene pro-
moter, which drives Cre expression in this particular
strain and is heavily involved in melanin synthesis under
normal conditions.27
Findings described in this study suggest that some of
the phenotypes described in prior RPE-specific knockout
studies that used Trp1-Cre mice may have been a com-
bination of the targeted loxP gene excision and/or the Cre
transgene presence toxicity itself (Table 2).25,26,28–32 For
instance, retinal dystrophy with abnormal ERG responses
and decreased RPE65 expression have been reported
by two independent studies26,29 that used the Trp1-Cre
line to knockout RXR and Lrat, respectively, as we see in
Trp1-Cre alone. Similarly, areas of hyperfluorescence
that increased in intensity over time but not in size (win-
dow defect) on FA have been reported as a result of
conditional ablation of vascular endothelial growth factor
in the RPE.25 In addition, the mosaic nature of the Cre
toxicity phenotype necessitates that as proper controls
panoramic investigation of the RPE monolayer should be
included in RPE conditional knockout studies. Therefore,
on the basis of our findings in this study, we may need to
re-evaluate the conclusions drawn from previous studies
that used the Trp1-Cre mouse.21–27
Another interesting finding of this study is the activation
of the retinal microglia and its subsequent migration to
the subretinal space, which is normally devoid of immune
cells.21 The RPE plays an important role in keeping the
retinal microglia in a ramified-quiescent state through the
secretion of immunosuppressive cytokines such as trans-
forming growth factor-, IL-10, and pigment epithelium-
derived factor among others.33 Indeed, IL-10 protein
levels were found to be significantly decreased in cho-
roid-RPE lysates from Trp1-Cre mice compared with wild-
type controls (see Supplemental Figure S3N at http://ajp.
amjpathol.org), which may partially explain the profound
activation. However, it is not clear whether the reduction
in IL-10 was because of a decrease in RPE cell number or
because of a general manifestation of RPE dysfunction.
In our study, the retinal microglia were strongly associ-
ated with areas of damaged RPE cells and phagocytosed
cellular debris most likely originating from RPE cells. It is
plausible that microglial cells play a role in repopulating
and remodeling the RPE monolayer after dysfunction or
cell death with the aim of maintaining its integrity. This is
further supported by several recent studies showing that
activated subretinal microglia can influence the function
of RPE cells or even change their morphology.34,35 The
accumulation of activated subretinal microglia has been
reported in specimens from patients with dry age-related
macular degeneration.36 Further investigations are needed
to fully elucidate the interplay between the RPE and the
retinal microglia.
To date, six mouse lines expressing Cre recombinase
in the RPE have been reported in the literature,13,37–41 yet
this is the first report to indicate potential problems
caused by prolonged and robust Cre expression by the
RPE. The possibility of such toxicity effect should alert
investigators using other lines expressing Cre in the RPE.Although the use of transgenic animals with high levels of
Cre expression can ensure a high recombination level,
they may also pose a significant risk of Cre-mediated
cellular toxicity potentially because of nonspecific “illegit-
imate” recombination events.9 To avoid this complication,
several strategies have been developed to control Cre ex-
pression such as induction via tamoxifen or tetracycline
administration or the use of self-deleting Cre-expressing
vectors.42 Despite these efforts, issues of toxicity remain
even with ligand-dependent recombinases.43,44 Therefore,
it is clear that inclusion of the most crucial control, namely
mice carrying the Cre transgene, and a comprehensive
investigation of the RPE flat mount should always be in-
cluded in conditional gene targeting studies for accurate
interpretation of scientific results.
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